Cargando…
Immunotherapy for pancreatic cancer: Barriers and breakthroughs
Immunotherapy is a rapidly growing field and represents a paradigm shift in the treatment of malignancies as it offers a new therapeutic approach beyond surgery, conventional chemotherapy, and radiation treatment. Targeting immune checkpoints, such as cytotoxic T‐lymphocyte‐associated antigen 4 and...
Autores principales: | Torphy, Robert J., Zhu, Yuwen, Schulick, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036358/ https://www.ncbi.nlm.nih.gov/pubmed/30003190 http://dx.doi.org/10.1002/ags3.12176 |
Ejemplares similares
-
Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy
por: Torphy, Robert J., et al.
Publicado: (2017) -
Anaplastic Pancreatic Carcinoma Arising Within a Mucinous Cystic Neoplasm of the Pancreas: A Case Report and a Brief Review of the Literature
por: Paniccia, Alessandro, et al.
Publicado: (2017) -
The GPR171 pathway suppresses T cell activation and limits antitumor immunity
por: Fujiwara, Yuki, et al.
Publicado: (2021) -
Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
por: Igarashi, Yuka, et al.
Publicado: (2020) -
Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment
por: Yang, Ling, et al.
Publicado: (2022)